Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SAB Biotherapeutics (SABS) Asset Utilization Ratio: 2021-2025

Historic Asset Utilization Ratio for SAB Biotherapeutics (SABS) over the last 4 years, with Sep 2025 value amounting to -0.00.

  • SAB Biotherapeutics' Asset Utilization Ratio fell 102.36% to -0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.00, marking a year-over-year decrease of 102.36%. This contributed to the annual value of 0.02 for FY2024, which is 37.84% down from last year.
  • Per SAB Biotherapeutics' latest filing, its Asset Utilization Ratio stood at -0.00 for Q3 2025, which was up 79.46% from -0.00 recorded in Q2 2025.
  • SAB Biotherapeutics' Asset Utilization Ratio's 5-year high stood at 0.75 during Q1 2022, with a 5-year trough of -0.00 in Q2 2025.
  • Its 3-year average for Asset Utilization Ratio is 0.07, with a median of 0.03 in 2024.
  • Data for SAB Biotherapeutics' Asset Utilization Ratio shows a maximum YoY crashed of 106.83% (in 2025) over the last 5 years.
  • Quarterly analysis of 5 years shows SAB Biotherapeutics' Asset Utilization Ratio stood at 0.61 in 2021, then fell by 24.79% to 0.46 in 2022, then crashed by 91.37% to 0.04 in 2023, then plummeted by 36.32% to 0.03 in 2024, then tumbled by 102.36% to -0.00 in 2025.
  • Its last three reported values are -0.00 in Q3 2025, -0.00 for Q2 2025, and 0.01 during Q1 2025.